Skip to main content
. 2013 Dec 17;306(4):E388–E398. doi: 10.1152/ajpendo.00124.2013

Fig. 5.

Fig. 5.

ALG, but not PGZ, reduced dipeptidyl peptidase (DPP IV) activity and the concentration of free fatty acid in plasma. Effect of 14-day treatment with PGZ, ALG, and PGZ + ALG on plasma DPP IV activity (A) and plasma free fatty acid (B). *P < 0.05 vs. Veh; #P < 0.05 vs. PGZ alone; n = 7–10/group.